Voya Financial (VOYA – Research Report) received a Hold rating and price target from Truist Financial analyst Mark Hughes today. The company’s shares closed yesterday at $72.22. Leverage the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Voya Investment Management reported $339.4 billion in assets under management as of Dec. 31, up over 5% from $321.7 billion a year earlier, but a slight decrease from $340.5 billion reported three ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Voya Financial, Inc. VOYA reported fourth-quarter 2024 adjusted operating earnings of $1.50 per share, which beat the Zacks Consensus Estimate by more than two-fold. The bottom line decreased 23.8 ...
As of January 30 at 10:44:03 a.m. EST. Market Open.
Sun Life Financial Inc. (NYSE: SLF) delivered second-quarter 2024 underlying net income of $1.25 per share, which beat the Zacks Consensus Estimate by 5.9%. The bottom line increased 6.8% year ...
After hours: February 5 at 6:19:26 PM EST ...
Investors with a lot of money to spend have taken a bullish stance on Teva Pharmaceutical Indus TEVA ... 20-year pro options trader reveals his one-line chart technique that shows when to buy ...
Analyst Jason Gerberry from Bank of America Securities reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report) and increased the price target to $26.00 from $25.00. Discover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results